PANC 08.13 Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The PANC 08.13 cell line, also known as PL9, is a pancreatic cancer cell model derived from adenocarcinoma. It has been included in studies focused on understanding genomic variations, including allelic loss, homozygous deletions, and broader chromosomal instability. This cell line is part of an extensive set of pancreatic cancer models used to analyze somatic alterations in cancer cells, particularly in the absence of matched normal tissues, making it ideal for high-resolution genetic mapping. In a study utilizing Affymetrix 100K SNP arrays, PANC 08.13 was examined alongside 25 other pancreatic cancer cell lines. These arrays allowed for high-density analysis of single nucleotide polymorphisms (SNPs) and revealed the allelic status across the genome without requiring matched normal samples. Such studies help identify critical regions of allelic loss (LOH), gene deletions, and chromosomal recombination events, which are frequent in pancreatic cancer cells. PANC 08.13’s genetic characterization includes frequent mutations in driver genes typically associated with pancreatic cancer, such as KRAS, TP53, CDKN2A, and SMAD4. These genetic defects are hallmarks of pancreatic ductal adenocarcinoma and contribute to uncontrolled cellular proliferation, disrupted cell cycle regulation, and defective apoptosis mechanisms. Studies leveraging cell lines like PANC 08.13 allow for the development of targeted therapies and the identification of novel therapeutic vulnerabilities in pancreatic cancer. |
|---|---|
| Organism | Human |
| Tissue | Pancreas |
| Disease | Adenocarcinoma |
| Applications | 3D cell culture, Cancer research |
| Synonyms | Panc 8.13, Panc-08.13, PANC-08-13, Panc_08_13, Panc08.13, Panc8.13, Panc-8_13, Panc-813, PANC 813, Panc813, PANC813, PANC0813, Panc0813, Pa14C, PL9, PL-9 |
Characteristics
| Age | 85 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Cell type | Epithelial cell |
| Growth properties | Adherent |
Regulatory Data
| Citation | PANC 08.13 (Cytion catalog number 305391) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1638 |
Biomolecular Data
| Antigen expression | MHC class I +; MHC class II - |
|---|---|
| Oncogenes | K-ras+ |
| Tumorigenic | Yes; Yes in nude or SCID mice |
| Mutational profile | Mutation: KRAS, Simple, p.Gly12Asp (c.35G>A), Homozygous; Mutation: SMAD4, Simple, p.Cys123Metfs*2 (c.366dupA) (c.366_367insA), Homozygous |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 15% FBS |
| Dissociation Reagent | Trypsin-EDTA |
| Doubling time | 20 hours |
| Subculturing | For routine adherent cell culture: Aspirate the old culture medium from the adherent cells, and wash them with PBS to remove any remaining medium. After aspirating the PBS, add the appropriate volume of Trypsin/EDTA solution based on the culture vessel size (e.g., 1 ml for a T25 flask, 3 ml for a T75 flask) and incubate at room temperature or 37°C until the cells detach (5-10 minutes). Monitor detachment under a microscope, and gently tap the vessel if necessary to release the cells. Once detached, add complete medium to inactivate the Trypsin/EDTA, gently resuspend the cells, and transfer an aliquot of the cell suspension into a new culture vessel containing fresh medium. Place the vessel in an incubator set to 37°C with 5% CO2, and change the medium every 2-3 days. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
-
Related products
Related products
Panc02 CellsOrganism Mouse Tissue Pancreas Disease Mouse pancreatic ductal adenocarcinoma CAD$1,104.00*Panc 10.05 CellsOrganism Human Tissue Pancreas Disease Pancreatic ductal adenocarcinoma CAD$621.00*